Publication | Closed Access

Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)

Risk-adapted RecommendationsAdjuvant CarboplatinUrologySurgical OncologyPatient AutonomyGenitourinary CancerMedicineCancer ManagementCancer TreatmentOncologyCancer ResearchTesticular Tumours